Journal article
MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE
Abstract
Children diagnosed with medulloblastoma (MB) that are refractory to upfront therapy or experience recurrence have very poor prognoses. Reports of phase I and II studies for these children exist, but these therapies bear significant treatment related morbidity and mortality. A retrospective review of children diagnosed with a pediatric MB from 2002-2015 from the McMaster Pediatric Brain Tumour Study Group (PBTSG) captured a number of pediatric …
Authors
Kameda-Smith M; Wang A; Abdulhadi N; Adile A; Ajani O; Yarascavitch B; Farrokhyar F; Tina P; Samaan C; Alyman C
Journal
Neuro-Oncology, Vol. 20, No. suppl_2, pp. i119–i119
Publisher
Oxford University Press (OUP)
Publication Date
June 22, 2018
DOI
10.1093/neuonc/noy059.407
ISSN
1522-8517